These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 15375785)

  • 1. Apolipoprotein C-III protein concentrations and gene polymorphisms in type 1 diabetes: associations with lipoprotein subclasses.
    Klein RL; McHenry MB; Lok KH; Hunter SJ; Le NA; Jenkins AJ; Zheng D; Semler AJ; Brown WV; Lyons TJ; Garvey WT;
    Metabolism; 2004 Oct; 53(10):1296-304. PubMed ID: 15375785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein C-III protein concentrations and gene polymorphisms in Type 1 diabetes: associations with microvascular disease complications in the DCCT/EDIC cohort.
    Klein RL; McHenry MB; Lok KH; Hunter SJ; Le NA; Jenkins AJ; Zheng D; Semler A; Page G; Brown WV; Lyons TJ; Garvey WT;
    J Diabetes Complications; 2005; 19(1):18-25. PubMed ID: 15642486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of genotypes at the apolipoprotein AI-CIII-AIV, apolipoprotein B and lipoprotein lipase gene loci with coronary atherosclerosis and high density lipoprotein subclasses.
    Peacock RE; Hamsten A; Johansson J; Nilsson-Ehle P; Humphries SE
    Clin Genet; 1994 Oct; 46(4):273-82. PubMed ID: 7834891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the combination of methyltestosterone and esterified estrogens compared with esterified estrogens alone on apolipoprotein CIII and other apolipoproteins in very low density, low density, and high density lipoproteins in surgically postmenopausal women.
    Chiuve SE; Martin LA; Campos H; Sacks FM
    J Clin Endocrinol Metab; 2004 May; 89(5):2207-13. PubMed ID: 15126543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear magnetic resonance-determined lipoprotein subclass profile in the DCCT/EDIC cohort: associations with carotid intima-media thickness.
    Lyons TJ; Jenkins AJ; Zheng D; Klein RL; Otvos JD; Yu Y; Lackland DT; McGee D; McHenry MB; Lopes-Virella M; Garvey WT;
    Diabet Med; 2006 Sep; 23(9):955-66. PubMed ID: 16922701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance.
    Garvey WT; Kwon S; Zheng D; Shaughnessy S; Wallace P; Hutto A; Pugh K; Jenkins AJ; Klein RL; Liao Y
    Diabetes; 2003 Feb; 52(2):453-62. PubMed ID: 12540621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephropathy.
    Jenkins AJ; Lyons TJ; Zheng D; Otvos JD; Lackland DT; McGee D; Garvey WT; Klein RL;
    Kidney Int; 2003 Sep; 64(3):817-28. PubMed ID: 12911531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation at the lipoprotein lipase and apolipoprotein AI-CIII gene loci are associated with fasting lipid and lipoprotein traits in a population sample from Iceland: interaction between genotype, gender, and smoking status.
    Peacock RE; Temple A; Gudnason V; Rosseneu M; Humphries SE
    Genet Epidemiol; 1997; 14(3):265-82. PubMed ID: 9181356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study.
    Russo GT; Meigs JB; Cupples LA; Demissie S; Otvos JD; Wilson PW; Lahoz C; Cucinotta D; Couture P; Mallory T; Schaefer EJ; Ordovas JM
    Atherosclerosis; 2001 Sep; 158(1):173-81. PubMed ID: 11500189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort.
    Lyons TJ; Jenkins AJ; Zheng D; Lackland DT; McGee D; Garvey WT; Klein RL
    Invest Ophthalmol Vis Sci; 2004 Mar; 45(3):910-8. PubMed ID: 14985310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum lipoproteins in the diabetes control and complications trial/epidemiology of diabetes intervention and complications cohort: associations with gender and glycemia.
    Jenkins AJ; Lyons TJ; Zheng D; Otvos JD; Lackland DT; McGee D; Garvey WT; Klein RL;
    Diabetes Care; 2003 Mar; 26(3):810-8. PubMed ID: 12610042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA polymorphisms at the apolipoprotein A1-CIII loci in Taiwanese: correlation of plasma APOCIII with triglyceride level and body mass index.
    Wu JH; Kao JT; Wen MS; Lo SK
    J Formos Med Assoc; 2000 May; 99(5):367-74. PubMed ID: 10870325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in Type 1 diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study.
    Soedamah-Muthu SS; Chang YF; Otvos J; Evans RW; Orchard TJ;
    Diabetologia; 2003 May; 46(5):674-82. PubMed ID: 12743701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum cholesterol and triglyceride reference ranges of twenty lipoprotein subclasses for healthy Japanese men and women.
    Furusyo N; Ai M; Okazaki M; Ikezaki H; Ihara T; Hayashi T; Hiramine S; Ura K; Kohzuma T; Schaefer EJ; Hayashi J
    Atherosclerosis; 2013 Dec; 231(2):238-45. PubMed ID: 24267234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear magnetic resonance-determined lipoprotein subclasses and carotid intima-media thickness in type 1 diabetes.
    Basu A; Jenkins AJ; Zhang Y; Stoner JA; Klein RL; Lopes-Virella MF; Garvey WT; Lyons TJ;
    Atherosclerosis; 2016 Jan; 244():93-100. PubMed ID: 26600440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes.
    Colhoun HM; Otvos JD; Rubens MB; Taskinen MR; Underwood SR; Fuller JH
    Diabetes; 2002 Jun; 51(6):1949-56. PubMed ID: 12031985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of omega-3 carboxylic acids on apolipoprotein CIII-containing lipoproteins in severe hypertriglyceridemia.
    Morton AM; Furtado JD; Lee J; Amerine W; Davidson MH; Sacks FM
    J Clin Lipidol; 2016; 10(6):1442-1451.e4. PubMed ID: 27919362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving Assessment of Lipoprotein Profile in Type 1 Diabetes by 1H NMR Spectroscopy.
    Brugnara L; Mallol R; Ribalta J; Vinaixa M; Murillo S; Casserras T; Guardiola M; Vallvé JC; Kalko SG; Correig X; Novials A
    PLoS One; 2015; 10(8):e0136348. PubMed ID: 26317989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial.
    Sacks FM; Alaupovic P; Moye LA; Cole TG; Sussex B; Stampfer MJ; Pfeffer MA; Braunwald E
    Circulation; 2000 Oct; 102(16):1886-92. PubMed ID: 11034934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.